nach oben

Erschienen in:

2024 | OriginalPaper | Buchkapitel

20. Übelkeit und Erbrechen

verfasst von : Franziska Jahn, Karin Jordan

Erschienen in: Onkologische Krankenpflege

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Pflegende übernehmen vor, während und nach onkologischen Therapien eine wichtige Rolle bei der Prophylaxe und der Symptomkontrolle von Übelkeit und Erbrechen. Fundierte Kenntnisse zur Behandlung und Entstehung sowie zu Auswirkungen von Übelkeit und Erbrechen sorgen für zielgerichtete pflegerische Interventionen und können an Patienten und Angehörige weitergegeben werden.

Vorheriges Kapitel Ernährung

Nächstes Kapitel Diarrhö und Obstipation

Basch E et al (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29:4189–4198CrossRefPubMedPubMedCentral

Gralla RJ et al (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin Oncol 17:2971–2994CrossRefPubMed

Grunberg SM et al (2004) Incidence of chemotherapy- induced nausea and emesis after modern antiemetics: perception versus reality. Cancer 100:2261–2268CrossRefPubMed

Hesketh PJ et al (2020) Antiemetics: ASCO guideline update. J Clin Oncol 38(24):2782–2797CrossRefPubMed

Jahn F, Wörmann B, Brandt J, Freidank A, Feyer P, Jordan K (2022) The prevention and treatment of nausea and vomiting during tumor therapy. Dtsch Arztebl Int. 119(21):382–392PubMedPubMedCentral

Jordan K et al (2015) Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review. Ann Oncol 26(6):1081–1090CrossRefPubMed

Jordan K et al (2017) Supportive treatments for patients with cancer. Dtsch Arztebl Int 114(27–28):481–487PubMedPubMedCentral

Majem M et al (2011) Perception of healthcare providers versus patient reported incidence of chemotherapy-induced nausea and vomiting after the addition of NK-1 receptor antagonists. Supportive Care Cancer 19:1983–1990CrossRef

Roila F et al (2016) 2016 MASCC and ESMO guideline update for the prevention of chemotherapy and radiotherapy -induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol 27(Supp 5):v119–v133CrossRefPubMed

Ruhlmann CH, Jahn F, Jordan K, Dennis K, Maranzano E, Molassiotis A, Roila F, Feyer P (2017) 2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting. Support Care Cancer 25:309–316CrossRefPubMed

Saito M, Aogi K, Sekine I et al (2009) Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. Lancet Oncol 10:115–124CrossRefPubMed

Grunberg SM et al (2011) Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity-state of the art. Support Care Cancer 19(Suppl 1): S43–S47

Herrstedt J et al (2011) Acute emesis: moderately emetogenic chemotherapy. Support Care Cancer 19:S15–S23CrossRefPubMed

Kris MG et al (2011) Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy. Support Care Cancer 19(Suppl 1):S25–S32CrossRefPubMed

Molassiotis A, Aapro M et al (2014) Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study. J Pain Symptom Manage 47(5):839–848CrossRefPubMed

Oliver I et al (2011) Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential. Support Care Cancer 19(Suppl):S33–S36CrossRef

Roila F et al (2011) Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only). Support Care Cancer 19(Suppl 1):S57–S62CrossRefPubMed

European Medical Oncology Society: (www.esmo.org Antiemetic Guidelines)

Multinational Association for Supportive Care in Cancer: www.mascc.org (Antiemetic Guidelines 2013)

National Comprehensive Cancer Network (www.nccn.org Antiemesis Guidelines)

Oncology Nursing Society. www.ons.org (Evidence based practice-PEP (Putting Evidence into Practice) – nausea/vomiting)

Titel: Übelkeit und Erbrechen
verfasst von: Franziska Jahn
Karin Jordan
Verlag: Springer Berlin Heidelberg
Buch: Onkologische Krankenpflege
Print ISBN: 978-3-662-67416-1

Electronic ISBN: 978-3-662-67417-8

Copyright-Jahr: 2024
DOI: https://doi.org/10.1007/978-3-662-67417-8_20

Springerpflege

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten